Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program

BB Poindexter, R Feng, B Schmidt… - Annals of the …, 2015 - atsjournals.org
BB Poindexter, R Feng, B Schmidt, JL Aschner, RA Ballard, A Hamvas, AM Reynolds…
Annals of the American Thoracic Society, 2015atsjournals.org
Rationale: Bronchopulmonary dysplasia is the most common morbidity of prematurity, but
the validity and utility of commonly used definitions have been questioned. Objectives: To
compare three commonly used definitions of bronchopulmonary dysplasia in a
contemporary prospective, multicenter observational cohort of extremely preterm infants.
Methods: At 36 weeks postmenstrual age, the following definitions of bronchopulmonary
dysplasia were applied to surviving infants with and without imputation: need for …
Rationale: Bronchopulmonary dysplasia is the most common morbidity of prematurity, but the validity and utility of commonly used definitions have been questioned.
Objectives: To compare three commonly used definitions of bronchopulmonary dysplasia in a contemporary prospective, multicenter observational cohort of extremely preterm infants.
Methods: At 36 weeks postmenstrual age, the following definitions of bronchopulmonary dysplasia were applied to surviving infants with and without imputation: need for supplemental oxygen (Shennan definition), National Institutes of Health Workshop definition, and “physiologic” definition after a room-air challenge.
Measurements and Main Results: Of 765 survivors assessed at 36 weeks, bronchopulmonary dysplasia was diagnosed in 40.8, 58.6, and 32.0% of infants, respectively, with the Shennan, workshop and physiologic definitions. The number of unclassified infants was lowest with the workshop definition (2.1%) and highest with the physiologic definition (16.1%). After assigning infants discharged home in room air before 36 weeks as no bronchopulmonary dysplasia, the modified Shennan definition compared favorably to the workshop definition, with 2.9% unclassified infants. Newer management strategies with nasal cannula flows up to 4 L/min or more and 0.21 FiO2 at 36 weeks obscured classification of bronchopulmonary dysplasia status in 12.4% of infants.
Conclusions: Existing definitions of bronchopulmonary dysplasia differ with respect to ease of data collection and number of unclassifiable cases. Contemporary changes in management of infants, such as use of high-flow nasal cannula, limit application of existing definitions and may result in misclassification. A contemporary definition of bronchopulmonary dysplasia that correlates with respiratory morbidity in childhood is needed.
Clinical trial registered with www.clinicaltrials.gov (NCT01435187).
ATS Journals